TY - CHAP PY - 2006 DA - 2006// BT - Kidney and Urologic Diseases Statistics for the United States ID - ref1 ER - TY - JOUR AU - Committee, A. U. A. P. G. PY - 2003 DA - 2003// TI - AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations JO - J Urol VL - 170 UR - https://doi.org/10.1097/01.ju.0000078083.38675.79 DO - 10.1097/01.ju.0000078083.38675.79 ID - Committee2003 ER - TY - JOUR AU - Collins, M. M. AU - Barry, M. J. AU - Bin, L. AU - Roberts, R. G. AU - Oesterling, J. E. AU - Fowler, F. J. PY - 1997 DA - 1997// TI - Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians JO - J Gen Intern Med VL - 12 ID - Collins1997 ER - TY - JOUR AU - McConnell, J. D. AU - Roehrborn, C. G. AU - Bautista, O. M. AU - Andriole, G. L. AU - Dixon, C. M. AU - Kusek, J. W. AU - Lepor, H. AU - McVary, K. T. AU - Nyberg, L. M. AU - Clarke, H. S. AU - Crawford, E. D. AU - Diokno, A. AU - Foley, J. P. AU - Foster, H. E. AU - Jacobs, S. C. AU - Kaplan, S. A. AU - Kreder, K. J. AU - Lieber, M. M. AU - Lucia, M. S. AU - Miller, G. J. AU - Menon, M. AU - Milam, D. F. AU - Ramsdell, J. W. AU - Schenkman, N. S. AU - Slawin, K. M. AU - Smith, J. A. PY - 2003 DA - 2003// TI - The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa030656 DO - 10.1056/NEJMoa030656 ID - McConnell2003 ER - TY - JOUR AU - Roehrborn, C. G. AU - Boyle, P. AU - Nickel, J. C. AU - Hoefner, K. AU - Andriole, G. AU - and, A. R. I. A. PY - 2002 DA - 2002// TI - Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia JO - Urology VL - 60 UR - https://doi.org/10.1016/S0090-4295(02)01905-2 DO - 10.1016/S0090-4295(02)01905-2 ID - Roehrborn2002 ER - TY - JOUR AU - Gades, N. M. AU - Jacobson, D. J. AU - Girman, C. J. AU - Roberts, R. O. AU - Lieber, M. M. AU - Jacobsen, S. J. PY - 2005 DA - 2005// TI - Prevalence of conditions potentially associated with lower urinary tract symptoms in men JO - BJU Int VL - 95 UR - https://doi.org/10.1111/j.1464-410X.2005.05337.x DO - 10.1111/j.1464-410X.2005.05337.x ID - Gades2005 ER - TY - BOOK AU - Issa, M. M. AU - Marshall, F. F. PY - 2005 DA - 2005// TI - Contemporary diagnosis and management of diseases of the prostate PB - Handbooks in Health Care Co CY - Newtown, Pa ID - Issa2005 ER - TY - STD TI - Kaplan SA: 2006, New York, Weill Medical College of New York University, Vol. 1, No. 1: Benign Prostatis Hyperplasia and Enlarged Prostate Guidelines: How They Can Be Useful to Primary Care, Weill Medical College of New York University Reports on Men's Urologic Health, ID - ref8 ER - TY - JOUR AU - Roehrborn, C. G. PY - 1998 DA - 1998// TI - Accurate determination of prostate size via digital rectal examination and transrectal ultrasound JO - Urology VL - 51 ID - Roehrborn1998 ER - TY - JOUR AU - Roberts, R. O. AU - Jacobsen, S. J. AU - Jacobson, D. J. AU - Rhodes, T. AU - Girman, C. J. AU - Lieber, M. M. PY - 2000 DA - 2000// TI - Longitudinal changes in peak urinary flow rates in a community based cohort JO - J Urol VL - 163 UR - https://doi.org/10.1016/S0022-5347(05)67984-0 DO - 10.1016/S0022-5347(05)67984-0 ID - Roberts2000 ER - TY - JOUR AU - Kawakami, J. AU - Nickel, J. C. PY - 1999 DA - 1999// TI - Acute urinary retention and surgery for benign prostatic hyperplasia: the patient's perspective JO - Can J Urol VL - 6 ID - Kawakami1999 ER - TY - JOUR AU - Choong, S. AU - Emberton, M. PY - 2000 DA - 2000// TI - Acute urinary retention JO - BJU Int VL - 85 UR - https://doi.org/10.1046/j.1464-410x.2000.00409.x DO - 10.1046/j.1464-410x.2000.00409.x ID - Choong2000 ER - TY - JOUR AU - Jacobsen, S. J. AU - Jacobson, D. J. AU - Girman, C. J. AU - Roberts, R. O. AU - Rhodes, T. AU - Guess, H. A. AU - Lieber, M. M. PY - 1997 DA - 1997// TI - Natural history of prostatism: risk factors for acute urinary retention JO - J Urol VL - 158 UR - https://doi.org/10.1016/S0022-5347(01)64508-7 DO - 10.1016/S0022-5347(01)64508-7 ID - Jacobsen1997 ER - TY - JOUR AU - Arrighi, H. M. AU - Metter, E. J. AU - Guess, H. A. AU - Fozzard, J. L. PY - 1991 DA - 1991// TI - Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging JO - Urology VL - 38 UR - https://doi.org/10.1016/0090-4295(91)80191-9 DO - 10.1016/0090-4295(91)80191-9 ID - Arrighi1991 ER - TY - JOUR AU - Djavan, B. AU - Chapple, C. AU - Milani, S. AU - Marberger, M. PY - 2004 DA - 2004// TI - State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia JO - Urology VL - 64 UR - https://doi.org/10.1016/j.urology.2004.07.031 DO - 10.1016/j.urology.2004.07.031 ID - Djavan2004 ER - TY - JOUR AU - Clark, R. V. AU - Hermann, D. J. AU - Cunningham, G. R. AU - Wilson, T. H. AU - Morrill, B. B. AU - Hobbs, S. PY - 2004 DA - 2004// TI - Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-030330 DO - 10.1210/jc.2003-030330 ID - Clark2004 ER - TY - JOUR AU - Bartsch, G. AU - Rittmaster, R. S. AU - Klocker, H. PY - 2000 DA - 2000// TI - Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia JO - Eur Urol VL - 37 UR - https://doi.org/10.1159/000020181 DO - 10.1159/000020181 ID - Bartsch2000 ER - TY - JOUR AU - Andriole, G. L. AU - Kirby, R. PY - 2003 DA - 2003// TI - Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia JO - Eur Urol VL - 44 UR - https://doi.org/10.1016/S0302-2838(03)00198-2 DO - 10.1016/S0302-2838(03)00198-2 ID - Andriole2003 ER - TY - JOUR AU - Debruyne, F. AU - Barkin, J. AU - van Erps, P. AU - Reis, M. AU - Tammela, T. L. AU - Roehrborn, C. AU - and, A. R. I. B. PY - 2004 DA - 2004// TI - Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia JO - Eur Urol VL - 46 UR - https://doi.org/10.1016/j.eururo.2004.05.008 DO - 10.1016/j.eururo.2004.05.008 ID - Debruyne2004 ER - TY - JOUR AU - McConnell, J. D. AU - Bruskewitz, R. AU - Walsh, P. AU - Andriole, G. AU - Lieber, M. AU - Holtgrewe, H. L. AU - Albertsen, P. AU - Roehrborn, C. G. AU - Nickel, J. C. AU - Wang, D. Z. AU - Taylor, A. M. AU - Waldstreicher, J. PY - 1998 DA - 1998// TI - The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group JO - N Engl J Med VL - 338 UR - https://doi.org/10.1056/NEJM199802263380901 DO - 10.1056/NEJM199802263380901 ID - McConnell1998 ER - TY - JOUR AU - Barkin, J. AU - Guimaraes, M. AU - Jacobi, G. AU - Pushkar, D. AU - Taylor, S. AU - van Vierssen Trip, O. B. PY - 2003 DA - 2003// TI - Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5alpha-reductase inhibitor dutasteride JO - Eur Urol VL - 44 UR - https://doi.org/10.1016/S0302-2838(03)00367-1 DO - 10.1016/S0302-2838(03)00367-1 ID - Barkin2003 ER - TY - JOUR AU - Baldwin, K. C. AU - Ginsberg, P. C. AU - Harkaway, R. C. PY - 2001 DA - 2001// TI - Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin for bladder outlet obstruction JO - Urol Int VL - 66 UR - https://doi.org/10.1159/000056576 DO - 10.1159/000056576 ID - Baldwin2001 ER -